The overall median survival time of 89 months, much longer than that of 17.5 months reported in a recent SOD-related clinical trial [15], could be due to the rarity of the A4V mutation in the Chinese ALS population, which was characterized by a survival time of 1–2 years. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.